Scorpius Holdings, Inc. (SCPX)
OTCMKTS · Delayed Price · Currency is USD
0.0120
0.00 (0.00%)
Mar 13, 2026, 4:00 PM EST
Scorpius Holdings Revenue
Scorpius Holdings had revenue of $229.84K in the quarter ending September 30, 2025, a decrease of -75.08%. This brings the company's revenue in the last twelve months to $1.72M, down -82.91% year-over-year. In the year 2024, Scorpius Holdings had annual revenue of $6.24M, down -10.75%.
Revenue (ttm)
1.72M
Revenue Growth
-82.91%
P/S Ratio
0.43
Revenue / Employee
18.86K
Employees
91
Market Cap
733.71K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.24M | -751.82K | -10.75% |
| Dec 31, 2023 | 6.99M | 6.62M | 1,789.60% |
| Dec 31, 2022 | 370.18K | -1.74M | -82.48% |
| Dec 31, 2021 | 2.11M | -835.16K | -28.33% |
| Dec 31, 2020 | 2.95M | -101.14K | -3.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SQZ Biotechnologies Company | 12.12M |
| Emmaus Life Sciences | 11.89M |
| EV Biologics | 9.47M |
| Lipella Pharmaceuticals | 389.78K |
| Eastgate Biotech | 137.64K |
| THC Farmaceuticals | 18.52K |
Scorpius Holdings News
- 11 months ago - Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia - GlobeNewsWire
- 11 months ago - Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining - GlobeNewsWire
- 11 months ago - Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal - GlobeNewsWire
- 11 months ago - NYSE American to Commence Delisting Proceedings Against Scorpius Holdings, Inc. (SCPX) - Business Wire
- 1 year ago - Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives - GlobeNewsWire
- 1 year ago - Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™ - GlobeNewsWire
- 1 year ago - Scorpius Holdings Cancels Planned Reverse Stock Split - GlobeNewsWire
- 1 year ago - Scorpius Holdings Announces Reverse Stock Split - GlobeNewsWire